MAXIMIZING ONCOLOGY ANALYSIS WITH BUILT-IN KRAS ASSAY EXPERT SERVICES AND RAS ASSAYS

within the fast evolving industry of oncology study, precise and successful mutation screening is essential for creating qualified therapies. The KRAS solutions Platform plays a pivotal job in this landscape by providing in depth alternatives for KRAS mutation profiling and Examination. KRAS mutations, present in around 95% of RAS-linked oncogenic